Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Structural basis of tetherin function.

Weissenhorn W, Miguet N, Aschman N, Renesto P, Usami Y, Gottlinger HG.

Curr HIV Res. 2012 Jun;10(4):298-306. Review.

PMID:
22524178
2.

Transmembrane interactions of HIV-1 Vpu and tetherin.

Guo F, Liang C.

Curr HIV Res. 2012 Jun;10(4):292-7. Review.

PMID:
22524177
3.

Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.

Kuhl BD, Sloan RD, Donahue DA, Liang C, Wainberg MA.

Virology. 2011 Sep 1;417(2):353-61. doi: 10.1016/j.virol.2011.06.012. Epub 2011 Jul 14.

4.

Emerging role of the host restriction factor tetherin in viral immune sensing.

Hotter D, Sauter D, Kirchhoff F.

J Mol Biol. 2013 Dec 13;425(24):4956-64. doi: 10.1016/j.jmb.2013.09.029. Epub 2013 Sep 26. Review.

PMID:
24075872
5.

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.

Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, Sata T, Tokunaga K.

J Biol Chem. 2009 Dec 11;284(50):35060-72. doi: 10.1074/jbc.M109.058305. Epub 2009 Oct 16.

6.

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, Towers GJ.

PLoS Pathog. 2009 May;5(5):e1000443. doi: 10.1371/journal.ppat.1000443. Epub 2009 May 22.

7.

Sites of action of HIV-1 Vpu in BST-2/tetherin downregulation.

Arias JF, Iwabu Y, Tokunaga K.

Curr HIV Res. 2012 Jun;10(4):283-91. Review.

PMID:
22524176
8.
9.

Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Vigan R, Neil SJ.

J Virol. 2010 Dec;84(24):12958-70. doi: 10.1128/JVI.01699-10. Epub 2010 Oct 6.

10.

Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.

Lv M, Wang J, Zhu Y, Wang X, Zuo T, Liu D, Zhang J, Wu J, Zhang H, Kong W, Yu X.

FEBS Lett. 2013 Jan 4;587(1):37-43. doi: 10.1016/j.febslet.2012.11.022. Epub 2012 Nov 28.

11.

Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.

Lopez LA, Yang SJ, Exline CM, Rengarajan S, Haworth KG, Cannon PM.

J Virol. 2012 May;86(10):5467-80. doi: 10.1128/JVI.06280-11. Epub 2012 Mar 7.

12.

HIV-1 Vpu and BST-2/tetherin: enemies at the gates.

Tokunaga K.

Curr HIV Res. 2012 Jun;10(4):275-6. No abstract available.

PMID:
22533470
13.

Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.

Mack K, Starz K, Sauter D, Langer S, Bibollet-Ruche F, Learn GH, Stürzel CM, Leoz M, Plantier JC, Geyer M, Hahn BH, Kirchhoff F.

J Virol. 2017 Feb 28;91(6). pii: e02177-16. doi: 10.1128/JVI.02177-16. Print 2017 Mar 15.

PMID:
28077643
14.

Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.

Kmiec D, Iyer SS, Stürzel CM, Sauter D, Hahn BH, Kirchhoff F.

MBio. 2016 Aug 16;7(4). pii: e00934-16. doi: 10.1128/mBio.00934-16.

15.

Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.

Lucas TM, Janaka SK, Stephens EB, Johnson MC.

PLoS One. 2012;7(12):e51741. doi: 10.1371/journal.pone.0051741. Epub 2012 Dec 19.

16.

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.

Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM.

Retrovirology. 2010 Jun 7;7:51. doi: 10.1186/1742-4690-7-51. Erratum in: Retrovirology. 2011;8:85.

17.

CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.

Ali MS, Hammonds J, Ding L, Spearman P.

PLoS One. 2010 Feb 2;5(2):e9005. doi: 10.1371/journal.pone.0009005.

18.

Tetherin restricts direct cell-to-cell infection of HIV-1.

Kuhl BD, Sloan RD, Donahue DA, Bar-Magen T, Liang C, Wainberg MA.

Retrovirology. 2010 Dec 24;7:115. doi: 10.1186/1742-4690-7-115.

19.

Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin.

Janvier K, Roy N, Berlioz-Torrent C.

Curr HIV Res. 2012 Jun;10(4):315-20. Review.

PMID:
22524180
20.

Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.

Dotson D, Woodruff EA, Villalta F, Dong X.

J Biol Chem. 2016 Feb 19;291(8):4236-46. doi: 10.1074/jbc.M115.708123. Epub 2016 Jan 7.

Supplemental Content

Support Center